Risk factor1
|
Number of studies included
|
N2
|
Heterogeneity2
|
Funnel plot asymmetry ( P-value)3
|
---|
I2(%)2
|
τ
2
|
P-value
|
---|
FI (mU/L)
|
18
|
1756
|
99.5
|
3.762 ± 1.511
|
<0.001
|
0.519
|
FG (mmol/L)
|
24
|
3897
|
99.4
|
0.013 ± 0.005
|
<0.001
|
0.774
|
SBP (mm Hg)
|
23
|
3443
|
99.4
|
7.474 ± 2.894
|
<0.001
|
0.771
|
HDL (mmol/L)
|
30
|
4218
|
99.8
|
0.007 ± 0.002
|
<0.001
|
0.577
|
TAG (mmol/L)
|
29
|
3908
|
99.8
|
0.050 ± 0.015
|
<0.001
|
0.855
|
BMI (kg/m2)
|
29
|
4160
|
99.8
|
0.881 ± 0.256
|
<0.001
|
0.587
|
- 1FI: Fasting insulin, FG: Fasting glucose, SBP: Systolic blood pressure, HDL: High density lipoprotein, TAG: Triacylglyceride, BMI: Body mass index.
- 2total number of participants, who concluded the interventions.
- 2I2 = heterogeneity (τ2) expressed as a percentage of total variance (τ2 + sample error).
- 3From Egger’s regression test.